January study showed serious increase in risk of inflammation of the heart muscle for those who have received an mRNA COVID vaccination.
QUICK FACTS:
- A study published by the JAMA Network shows 133% greater risk of myocarditis in those who have received an mRNA COVID vaccination according to Israel National News.
- U.S. Centers for Disease Control (CDC) and researchers from U.S. universities and hospitals, examined the effects of vaccination with products manufactured by Pfizer-BioNTech and Moderna to ascertain risk factors.
- The study, released on Jan. 25 2022 compared those who have received the vaccine with the “background” population, studying 1626 cases of myocarditis.
- Data from the CDC’s Vaccine Adverse Event Reporting System was cross-checked to ensure compliance with the CDC’s definition of myocarditis.
- The report also noted that due to the nature of the VAERS system, the number of reported incidents of the deadly illness likely underestimates the extent of the phenomenon.
CASE STUDY DETAILS:
- “1626 cases of myocarditis were studied, and the results showed that the Pfizer-BioNTech product was most associated with higher risk, with 105.9 cases per million doses after the second vaccine shot in the 16 to 17 age group for males, and 70.7 cases per million doses after the second shot in the 12 to 15 age group for males,” INN reported. “The 18 to 24 male age group also saw significantly higher rates of myocarditis for both Pfizer’s and Moderna’s products (52.4 and 56.3 cases per million respectively).
- “The study found that median time to symptom onset was two days, and that 82 percent of cases were in males, consistent with previous studies. Around 96 percent of affected people were hospitalized, with most treated with nonsteroidal anti-inflammatory drugs.
- “…given that vaccination is no longer considered a reliable way in which to avoid COVID infection, it is unclear whether this has any specific relevance to the cost-benefit analysis of COVID vaccination … In the meantime, the American Heart Association and the American College of Cardiology advise that people with myocarditis should refrain from competitive sports for three to six months, and only resume strenuous exercise after normal ECG and other test results are obtained. In addition, they advise that further mRNA vaccine doses should be deferred.
BACKGROUND:
- Concerns about adverse reactions to the COVID-19 vaccine have been on the rise, particularly in the context of mandatory vaccines for work and travel.
- Yahoo News reported on Feb. 9 about the case surrounding a Kansas woman who died of an allergic reaction to the vaccine and what the autopsy discovered.
- Another report from WHTM Harrisburg told about a woman who had a reaction within two minutes of receiving the vaccination.
- VAERS Analysis shows a reported 1.1 million adverse reactions to the COVID-19 reported with more than 26,000 reported as life-threatening and over 23,000 deaths credited to the shot.
